FASLG and neoplasm: Although LSEC initially prevents tumor cells from entering the liver by inducing cell death via the Fas-FasL pathway, with continuous stimulation of tumor cells, LSEC instead promotes tumor cell colonization in the liver by inducing angiogenesis, increases the adhesion of tumor cells to the endothelium, and promotes the immunosuppression of the tumor cells.